ProKidney (MEX:PROK) YoY EPS Growth : -22.13% (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is ProKidney YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. ProKidney's YoY EPS Growth for the quarter that ended in Jun. 2024 was -22.13%.

ProKidney's Earnings per Share (Diluted) for the three months ended in Jun. 2024 was MXN-2.93.

ProKidney YoY EPS Growth Historical Data

The historical data trend for ProKidney's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ProKidney YoY EPS Growth Chart

ProKidney Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

YoY EPS Growth

-112.62

26.08

-115.77

ProKidney Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
YoY EPS Growth	Get a 7-Day Free Trial										66.83	-19.89	21.64	7.94	-22.13

ProKidney YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

ProKidney's YoY EPS Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EPS Growth (A: Dec. 2023 )
=	(Earnings per Share (Diluted) (A: Dec. 2023 )	-	Earnings per Share (Diluted) (A: Dec. 2022 ))	/	\| Earnings per Share (Diluted) (A: Dec. 2022 ) \|
=	(-9.675	-	-4.484)	/	\| -4.484 \|
=	-115.77 %

ProKidney's YoY EPS Growth for the quarter that ended in Jun. 2024 is calculated as:

	YoY EPS Growth (Q: Jun. 2024 )
=	(Earnings per Share (Diluted) (Q: Jun. 2024 )	-	Earnings per Share (Diluted) (Q: Jun. 2023 ))	/	\| Earnings per Share (Diluted) (Q: Jun. 2023 )) \|
=	(-2.931	-	-2.4)	/	\| -2.4 \|
=	-22.13 %

ProKidney YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of ProKidney's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

ProKidney Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProKidney Corp (MEX:PROK) » Definitions » YoY EPS Growth

Comparable Companies

Traded in Other Exchanges

PROK:USA

Address

2000 Frontis Plaza Boulevard, Suite 250, Winston-Salem, NC, USA, 27103

Website

https://www.prokidney.com

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease.